KRAS c.185A>C ;(p.E62A)

Variant ID: 12-25380273-T-G

NM_004985.3(KRAS):c.185A>C;(p.E62A)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Pan-cancer clinical impact of latent drivers from double mutations.

Communications Biology
Yavuz, Bengi Ruken BR; Tsai, Chung-Jung CJ; Nussinov, Ruth R; Tuncbag, Nurcan N
Publication Date: 2023-02-20

Variant appearance in text: KRAS: E62A
PubMed Link: 36808143
Variant Present in the following documents:
  • 42003_2023_4519_MOESM3_ESM.xlsx, sheet 3
View BVdb publication page



Combination of PD-1 Inhibitor and OX40 Agonist Induces Tumor Rejection and Immune Memory in Mouse Models of Pancreatic Cancer.

Gastroenterology
Ma, Ying Y; Li, Jun J; Wang, Huamin H; Chiu, Yulun Y; Kingsley, Charles V CV; Fry, David D; Delaney, Samantha N SN; Wei, Spencer C SC; Zhang, Jianhua J; Maitra, Anirban A; Yee, Cassian C
Publication Date: 2020-07

Variant appearance in text: KRAS: E62A
PubMed Link: 32179091
Variant Present in the following documents:
  • Main text
View BVdb publication page